- Companies
- Summa Health
Summa Health Acquisition, Valuation, Funding & Investors
Summa Health was acquired by General Catalyst for $515M in January 2024, a 0.3x multiple on $2B of revenue.
Summa Health acquisition price
$515M
Acquired by General Catalyst · Jan 2024
Summa Health revenue at acquisition
$2B
Last twelve months · Jan 2024
Summa Health revenue multiple at acquisition
0.3x
EV/Revenue · Jan 2024
Cumulative funding Summa Health raised
$6M
across 1 funding round
About Summa Health
Summa Health is an Akron-based integrated health system operating hospitals, outpatient centers, and cancer institutes in Northeast Ohio. Formed in 1998 through merger, it includes Akron City Hospital and Summa Health System - Akron Campus with over 800 beds total. Summa's cancer centers deploy Varian TrueBeam radiotherapy and genomic profiling for personalized treatments in breast, lung, and prostate cancers. The system partners with Case Western Reserve University for clinical research trials.
Founded
1989
HQ
Website
Status
Acquired
Customer focus
B2C
Revenue model
Services
Revenue
$2B (Jan 2024)
Valuation
$515M (acquired Jan 2024)
Sectors
Summa Health Acquisition
Summa Health was acquired by General Catalyst for $515M on 17 January 2024.
The acquisition price implies a 0.3x revenue multiple on $2B of revenue.
Before the acquisition Summa Health had raised $6M across 1 funding round.
Summa Health, one of Ohio's largest integrated delivery systems with over 130 years of history, operates two acute care hospitals, one rehab hospital, a network of community medical centers and physician offices, and a health insurance arm called SummaCare, serving the greater Akron region. General Catalyst, a global investment and transformation company and leading healthcare investor with over 100 active healthcare-focused portfolio companies and partnerships with more than 20 health systems, formed Health Assurance Transformation Company (HATCo) in late 2023 as a foundational element of its healthcare strategy to innovate health system operations. HATCo, led by former Intermountain CEO Dr. Marc Harrison and backed by General Catalyst CEO Hemant Taneja, acquired Summa Health to create the first hospital operator owned by a venture capital firm, using it as a 'test kitchen' or proving ground for technologies from its portfolio to build modern, tech-enabled delivery platforms focused on value-based care, proactive health assurance, and enhanced patient experience. The deal, announced with a non-binding letter of intent in January 2024, received conditional approval from Ohio Attorney General Dave Yost and closed in November 2024 for a total purchase price of approximately $485-515 million, converting the nonprofit Summa Health to a for-profit entity. HATCo funded the acquisition from General Catalyst's balance sheet outside its typical fund structure to enable long-term commitment rather than a quick flip, committing an additional $200 million for strategic and transformative investments over seven years, $350 million in capital for technology and resources in the first five years, and $15 million to a foundation for community health in Akron. Proceeds address Summa's long-term debt amid recent operational challenges, despite investment income returning it to profitability, while providing access to General Catalyst's ecosystem for innovation without provider-typical risk aversion or cash shortfalls. Leaders emphasized reshaping healthcare delivery: Taneja described it as a blueprint for a resilient, affordable, proactive system; Harrison focused on operational stability and transformation; and Summa CEO Dr. Cliff Deveny highlighted building on strengths with new technology opportunities. The transaction aligns with General Catalyst's 2019 health assurance thesis, recent $8 billion capital raise including for healthcare, and broader ecosystem engagement, retaining Summa's nonprofit mission elements like community access, uninsured care, all-payer acceptance, medical education, and full employee retention.
| Acquirer | Date | Type | Price | EV/Revenue |
|---|---|---|---|---|
| 17 Jan 2024 | PE buyout | $515M | 0.3x |
Summa Health Funding History
Summa Health has raised a total of $6M across 1 funding round.
Summa Health funding rounds
| Date | Stage | Raised |
|---|---|---|
| Oct 2015 | Series A | $6M |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialSumma Health Competitors
Summa Health competitors include listed companies like Chularat Hospital, Garofalo Health Care, Sikarin and Strata Critical Medical, and private ones like Tesis Labs LLC and Neuberg Diagnostics.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $520M | - | ||
| Publicly listed | $251M | $52M | $525M | 2.0x | ||
| Publicly listed | $559M | $83M | $548M | 1.4x | ||
| Publicly listed | $181M | $47M | $479M | - | ||
| Publicly listed | $197M | ($16M) | $476M | 1.7x | ||
| Private | $107M | - | $642M | 6.0x |
Summa Health Public Comps
Summa Health is no longer listed, but its public comps include Chularat Hospital, Garofalo Health Care, Sikarin, Strata Critical Medical, M1 Kliniken, Hermina Hospitals, Integral Diagnostics, Community Health Systems, Al-Maidan Dental Clinic and Auna.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $251M | $52M | 2.1x | 2.0x | 9.8x | 9.5x | |||
| $559M | $83M | 1.5x | 1.4x | 9.8x | 8.6x | |||
| $181M | $47M | 2.5x | - | 9.7x | - | |||
| $197M | ($16M) | 2.3x | 1.7x | (28.4x) | 16.4x | |||
| $420M | $46M | 0.9x | 1.7x | 8.6x | 9.8x | |||
| $402M | $104M | 2.1x | 1.9x | 8.1x | 7.5x | |||
| $561M | $99M | 1.8x | 1.8x | 10.2x | 8.4x | |||
| $12B | $2B | 0.9x | 0.9x | 5.5x | 8.0x | |||
This data is available for Pro users. Sign up to see all Summa Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Summa Health
| When was Summa Health founded? | Summa Health was founded in 1989. |
| Where is Summa Health headquartered? | Summa Health is headquartered in Akron, OH, United States. |
| Is Summa Health publicly listed? | No, Summa Health was acquired by General Catalyst in January 2024. |
| Who acquired Summa Health? | Summa Health was acquired by General Catalyst in January 2024. |
| How much was Summa Health acquired for? | Summa Health was acquired for $515M in January 2024, a 0.3x revenue multiple. |
| How much funding has Summa Health raised? | Summa Health has raised $6M across 1 funding round. |
| What was Summa Health's last funding round? | Summa Health's last funding round was a $6M Series A in October 2015. |
| Which companies are comparable to Summa Health? | Companies comparable to Summa Health include Tesis Labs LLC, Chularat Hospital, Garofalo Health Care, Sikarin, Strata Critical Medical and Neuberg Diagnostics. |
See companies similar to Summa Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




